|Bid||29.70 x 800|
|Ask||36.92 x 900|
|Day's Range||36.78 - 38.59|
|52 Week Range||31.31 - 47.22|
|Beta (3Y Monthly)||0.22|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, NY / ACCESSWIRE / August 20, 2019, 2018 / Premier, Inc. (North Carolina) (NASDAQ: PINC ) will be discussing their earnings results in their 2019 Fourth Quarter Earnings to be held on August 20, ...
In a new analysis of primary care clinics, Premier Inc. identified wide variation in staffing model composition, performance and costs. Premier® also found that skill mix is not necessarily a predictor of provider productivity. The analysis and opportunities for improvement were published in Premier’s latest Ready, Risk, Reward white paper titled “Optimizing Primary Care Model Design to Improve Performance.” Using its robust database of detailed physician practice information, which includes more than 30,000 clinicians, Premier benchmarked 2018 data from 257 family medicine and primary care practices.
Texas Health Resources and Premier Inc. (PINC) have formed a regional supply chain organization to further scale advancements in total cost management for healthcare providers across North Texas. Texas Health, which provides coordinated care across its 26 hospitals, physician group, trauma centers, outpatient facilities, and home health and preventive services, has worked with healthcare improvement company Premier for more than 20 years to deliver consistent high-quality, affordable care to its communities.
Premier Inc. (PINC) plans to report fiscal 2019 fourth-quarter and full-year financial results the morning of Aug. 20, 2019, followed by a conference call at 8 a.m. ET to discuss the results. During the conference call, Premier’s management will review the company’s performance for the three months and fiscal year ended June 30, 2019 and discuss management’s outlook for fiscal 2020. The conference call will be webcast live and can be accessed through a link provided on the investor relations page of Premier's website at investors.premierinc.com.
Sodium bicarbonate injection is most commonly used for urgent treatment of cardiac emergencies, such as cardiac arrest, heart attacks, strokes and other life-threatening emergencies. Limited supplies of the drug today are being imported from Australia under special U.S. Food and Drug Administration (FDA) rules that apply in shortages, but the costs for the imported product are 300 percent higher than the U.S. alternatives. Exela Pharma Sciences is a new producer of sodium bicarbonate, having just received approval for its Abbreviated New Drug Application (ANDA) from the FDA to begin manufacturing.
Premier Inc., a leading healthcare improvement company, has partnered with 26-year, industry expert John Gorman to support its portfolio of value-based payment services for Medicare Advantage providers and participants. Premier members are demanding more support as they build successful Medicare Advantage strategies. Gorman will work directly with Premier’s strategic advisory team to assist providers with Medicare Advantage strategies for success in their markets.
Boston Children’s Hospital, one of the largest pediatric medical centers in the U.S., has partnered with Premier Inc. (PINC), a leading healthcare improvement company, to foster optimal management of its supply chain portfolio. Ranked the #1 children's hospital in the nation by U.S. News & World Report, Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School.
Premier Inc. (PINC), a healthcare improvement company, is working with 10 leading hospitals on a perinatal collaborative designed to reach zero preventable maternal and neonatal harm and deaths. Over the next two years, hospitals in Premier’s Perinatal Collaborative will design, test and adopt evidenced-based improvement strategies that can be replicated, standardized and scaled nationally. The collaborative, which launched in June, is part of Premier’s Bundle of Joy™ Campaign to transform the quality, safety and cost of maternal and infant health.
Cysteine hydrochloride has been in shortage in the U.S. since 2015. This FDA-approved New Drug Application (NDA) for cysteine hydrochloride injection is held by Exela Pharma Sciences, LLC, a U.S.-based manufacturer. Current supplies of cysteine hydrochloride injection are imported from Canada under special FDA rules that allow shortage drugs to be sourced abroad if no domestic supplies are available.
Premier Inc. , a leading healthcare improvement company, has recognized dozens of hospitals, health systems and suppliers for their outstanding work to improve healthcare quality and costs.
Premier Inc. (PINC), a healthcare improvement company, and Pensiamo Inc., a cognitive supply chain company, have partnered to launch a new pharmaceutical supply chain solution that was co-developed with UPMC, a world-renowned healthcare provider and insurer. CognitiveRx™ is a comprehensive pharmaceutical supply chain solution that predicts, manages and solves for challenges related to drug shortages, inflation, declining reimbursement and other factors impacting the life sciences supply chain. UPMC, which owns Pensiamo, will be the first to implement CognitiveRx to more precisely monitor market demand signals, predict shortage risk and recommend inventory levels that support its ability to insulate patient care from supply disruption.
ProvideGx, LLC, a consolidated subsidiary of Premier Inc. (PINC) and a healthcare improvement company developing a more stable and reliable supply chain for generic drugs in short supply, is collaborating with Fresenius Kabi to help mitigate national shortages of injectable thiamine, lidocaine, diphenhydramine, hydromorphone and morphine sulfate. Fresenius Kabi, a 2018 recipient of the Food and Drug Administration’s (FDA’s) Drug Shortage Assistance Award, is a global healthcare company that is a leading developer, manufacturer and supplier of injectable medicines used in hospitals and clinics to treat patients with critical and chronic conditions.
Premier Inc. (PINC), a leading healthcare improvement company, is exiting its specialty pharmacy business to enhance the company’s focus on the continuing evolution of its core supply chain, enterprise analytics and performance improvement capabilities. On May 6, 2019, certain of Premier’s consolidated subsidiaries entered into a definitive asset purchase and sale agreement with ProCare Pharmacy, L.L.C., a subsidiary of CVS Health Corporation, under which Premier will sell certain assets related to its specialty pharmacy business for $22.5 million, plus up to an additional $20.0 million for inventory, each subject to adjustment. The transaction is expected to close in the current quarter ending June 30, 2019.
Premier Inc. (PINC), a leading healthcare improvement company, has expanded its partnership with Ballad Health, an integrated health system that serves 29 counties across four Southeastern states. Ballad Health will implement Premier’s performance improvement infrastructure and leverage strategic supply chain services to drive high-value care across its enterprise.
Premier Inc. (PINC), a leading healthcare improvement company, named Michael J. Alkire its new President and Craig S. McKasson its new Chief Administrative Officer. Alkire has served as Chief Operating Officer of Premier since 2013. In addition to serving as Chief Administrative Officer, McKasson will retain his role as Senior Vice President, Chief Financial Officer and Treasurer of Premier, as he has since 2013.
Premier Inc. (PINC) plans to report fiscal 2019 third-quarter financial results the morning of May 7, 2019, followed by a conference call at 8 a.m. ET to discuss the results. During the conference call, Premier’s management team will review the company’s performance for the three months ended March 31, 2019 and discuss management’s outlook for the remainder of fiscal 2019. The conference call will be webcast live and can be accessed through a link provided on the investor relations page of Premier's website at investors.premierinc.com.
Premier Inc. (PINC), a leading healthcare improvement company, has launched the Bundle of Joy™ campaign to raise the bar on the quality, safety and cost of care for mothers and babies across the U.S. Premier aims to build and deploy new care delivery models using evidence-based guidelines and best practices from around the nation, ultimately scaling proven advancements across the industry. “Our goal for the Bundle of Joy campaign is to ensure mothers and babies are always at the center of care and supported by the latest evidence, the best doctors and the most successful practices.
Healthcare providers are becoming more adept at preventing and treating the top cause of hospital deaths and the most expensive hospital-associated condition: sepsis. An analysis by Premier Inc. found that its member hospitals achieved a 15 percent decline in the incidence of hospital-associated sepsis over the last three years. Premier published the analysis in its latest data-driven report, Margin of Excellence: Lowering the Incidence and Severity of Hospital-Associated Sepsis, which highlights the major opportunities to treat sepsis in the hospital and reduce the frequency and severity of this life-threatening condition.
Premier Inc. (PINC), a leading healthcare improvement company, has been named one of the 2019 World’s Most Ethical Companies® by the Ethisphere® Institute. This year’s recognition marks the 12th straight year that Premier has received the Ethisphere Institute designation.
Premier Inc. (PINC), a leading healthcare improvement company, today released its inflation estimates for contracted and non-contracted pharmaceutical pricing for fiscal year 2020 (July 2019 – June 2020), projecting a 3.8 percent increase in total pharmaceutical costs. This inflation rate is approximately 0.4 percent lower than Premier’s fiscal year 2019 projections. “Premier’s superior pharmacy contracting team has been able to secure industry-leading pricing across our portfolio, saving our members millions over last year’s estimates,” said Michael J. Alkire, Chief Operating Officer, Premier.
Premier Inc. , a leading healthcare improvement company, announced today that its President and CEO, Susan DeVore, and Chief Financial Officer, Craig McKasson, will present at the Raymond James & Associates 40th Annual Institutional Investors Conference on March 5, 2019.
Premier Inc. (PINC), a leading healthcare improvement company, is implementing its enterprise resource planning (ERP) solution, as well as its cost accounting/patient analytics and budgeting/forecasting offerings at University Health System in San Antonio, Texas. A nationally-recognized teaching hospital and network of outpatient healthcare centers, University Health System is expanding its engagement with Premier due to its unique ability to quickly automate and standardize financial and operational processes, and improve performance. Premier’s ERP system is designed specifically for healthcare providers and combines industry-leading supply chain and financial capabilities with robust analytics and data.